Doublet Chemotherapy, Dose-reduced (75%) for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Feb 2024: Trial registered, NCT06275958
  2. 1 Jul 2024: Trial started, NCT06275958

The trials

NCT06275958: DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

State
Under way
Phase
Phase 3
People
587 planned
Started
1 Jul 2024
Primary completion
Jun 2028
Arms
Doublet therapy, dose-reduced (low toxicity risk based on G8)
Results
None posted
  1. 23 Feb 2024: Trial registered
  2. 1 Jul 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.